SCHEMBL20007220

SCHEMBL20007220

C=CC(=O)c1ccc(OC)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.49
TAS1R3 Q7RTX0 6/20 0.48
TAS1R1 Q7RTX1 6/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KMT2A Q03164 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
DPP4 P27487 2/20 0.47
TP53 P04637 2/20 0.47
CXCL12 P48061 1/20 0.47
HTT P42858 1/20 0.47
KCNH2 Q12809 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27977033 0.85 ABCG2 (0.50) ABCG2TAS1R3TAS1R1NPC1RAB9A
SCHEMBL30307376 0.84 CYP1A2 (0.63) ABCG2NPC1KMT2AMEN1ALDH1A1
SCHEMBL547153 0.84 CYP1A2 (0.63) ABCG2NPC1KMT2AMEN1ALDH1A1
SCHEMBL16959104 0.83 SMN1; SMN2 (0.44) TAS1R3TAS1R1NPC1RAB9AKMT2A
SCHEMBL28643734 0.81 TUBB1 (0.55) ABCG2RAB9AKMT2AMEN1ALDH1A1
SCHEMBL2091206 0.81 TAS1R3 (0.51) TAS1R3TAS1R1NPC1RAB9AKMT2A
SCHEMBL5585484 0.81 ALDH1A1 (0.59) ABCG2NPC1RAB9AKMT2AMEN1
SCHEMBL5585477 0.81 ALDH1A1 (0.59) ABCG2NPC1RAB9AKMT2AMEN1
SCHEMBL11575925 0.80 CYP1A2 (0.68) TAS1R3TAS1R1NPC1RAB9AKMT2A
SCHEMBL11320111 0.80 KMT2A (0.50) TAS1R3TAS1R1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2942345-B1 3,4,5-TRIMETHOXYSTYRYLARYLAMINOPROPENONES FOR THE TREATMENT OF CANCER COUNCIL SCIENT IND RES (IN) 2018-03-28 EP disclosed